These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6820928)

  • 21. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
    Buchanan RM; Arulanandam BP; Metzger DW
    J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interpretation of the laboratory results concerning the protective effect of vaccines].
    Berrón Morato S; Sanz Moreno JC; Martín García E; Salcedo Peláez C; Bermúdez Saugar MP; Vázquez Moreno JA
    Rev Esp Salud Publica; 1998; 72(5):431-3. PubMed ID: 9951337
    [No Abstract]   [Full Text] [Related]  

  • 23. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns.
    Mogensen TH; Paludan SR; Kilian M; Ostergaard L
    J Leukoc Biol; 2006 Aug; 80(2):267-77. PubMed ID: 16731773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization may suffice for licensure of conjugate vaccines.
    Robbins JB; Schneerson R; Szu SC; Bryla DA; Lin FY; Gotschlich EC
    Dev Biol Stand; 1998; 95():161-7. PubMed ID: 9855427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counterimmunoelectrophoresis (CIE) for rapid diagnosis of bacteremia and bacterial meningitis.
    Med Lett Drugs Ther; 1981 May; 23(9):43-4. PubMed ID: 6783824
    [No Abstract]   [Full Text] [Related]  

  • 26. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular size characterization of bacterial capsular polysaccharide vaccines with Sepharose CL-2B.
    McCauley JA; Mancinelli RJ; Downing GV; Robbins JB
    J Biol Stand; 1981 Oct; 9(4):461-8. PubMed ID: 7033224
    [No Abstract]   [Full Text] [Related]  

  • 28. Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.
    Myerowitz RL; Gordon RE; Robbins JB
    Infect Immun; 1973 Dec; 8(6):896-900. PubMed ID: 4150383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of new pediatric vaccines: progress and challenges].
    Siegrist CA
    Rev Med Suisse Romande; 1998 Apr; 118(4):395-401. PubMed ID: 9623292
    [No Abstract]   [Full Text] [Related]  

  • 31. Meningococcal polysaccharide vaccines.
    Gold R
    Hosp Pharm; 1977 Apr; 12(4):201. PubMed ID: 10305440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemoprophylaxis in meningitis].
    Otero MC; Calvo MA; Pérez-Tamarit D; Asensi F
    Rev Esp Quimioter; 1998 Jun; 11(2):118-27. PubMed ID: 9795296
    [No Abstract]   [Full Text] [Related]  

  • 33. Molecular size characterization of bacterial capsular polysaccharide vaccines by high performance liquid chromatography.
    Bussat B; Schulz D; Arminjon F; Valentin C; Armand J
    Biologicals; 1990 Apr; 18(2):117-21. PubMed ID: 2375858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attempted induction of interferon by bacterial vaccines in allergic and nonallergic humans.
    Johnstone DE; Douglas RG; Simon R
    Ann Allergy; 1974 Feb; 32(2):70-2. PubMed ID: 4149323
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemophilus influenzae type B polysaccharide-protein conjugates: model for a new generation of capsular polysaccharide vaccines.
    Schneerson R; Robbins JB; Barrera O; Sutton A; Habig WB; Hardegree MC; Chaimovich J
    Prog Clin Biol Res; 1980; 47():77-94. PubMed ID: 6970933
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of latex agglutination and coagglutination methods for the determination of bacterial antigens in cerebrospinal fluid].
    Ayaşlioğlu E; Sözen TH; Ozkan S
    Mikrobiyol Bul; 1993 Jul; 27(3):185-90. PubMed ID: 8361405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 38. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal vaccines.
    Carlson RE; Hering PJ
    Am Fam Physician; 1982 Feb; 25(2):50, 55. PubMed ID: 7058735
    [No Abstract]   [Full Text] [Related]  

  • 40. Childhood immunization guidelines: current and future.
    Zimmerman RK; Burns IT
    Prim Care; 1994 Dec; 21(4):693-715. PubMed ID: 7855158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.